Chronic obstructive pulmonary disease (COPD) symptoms in the morning, including
dyspnea and sputum production, affect patients' quality of life and limit their ability to carry …

Morning symptoms are common in chronic obstructive pulmonary disease (COPD). Many
COPD patients consider the morning as the most troublesome part of the day, in which they …

Introduction Aclidinium bromide/formoterol fumarate (AB/FF) 400/12 μg efficacy and safety
was demonstrated in two 6-month Phase III studies (AUGMENT and ACLIFORM) and a 12 …

Background LABA (long-acting β2-agonists) and/or LAMA (long-acting muscarinic
antagonists) represent the first treatment options for patients with symptomatic COPD …

Introduction: Chronic obstructive pulmonary disease (COPD) patients experience the
morning as the worst period of the day. Nevertheless, morning symptoms are not mentioned …

Inhaled bronchodilator therapy is a mainstay of treatment for chronic obstructive pulmonary
disease (COPD). Despite the number and types of treatments available, the control of …

Background Early morning respiratory symptoms impact quality of life and are often the most
troublesome for patients with COPD. Reduction in symptoms and their impact are important …

Background The morning tends to be the most difficult time of day for many patients with
chronic obstructive pulmonary disease (COPD) when symptoms can limit one's ability to …

Background: LABA (long-acting β2-agonists) and/or LAMA (long-acting muscarinic
antagonists) represent the first treatment options for patients with symptomatic COPD …

Morning symptoms are common in chronic obstructive pulmonary disease (COPD). Many
COPD patients consider the morning as the most troublesome part of the day, in which they …